Tradestie Institutional Equity Comparison Engine

THOR vs IART โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IART Overall Edge

IART Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Integra LifeSciences Holdings (IART) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, THOR trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus IART at 5.6x Forward P/E and 9.9% operating margin (+2.3% YoY). In options structure, THOR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against IART sits in BREAKDOWN (16th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner IART
THOR N/M vs IART 5.6x Fwd P/E
Growth & Margin Winner IART
Op Margin N/A vs 9.9% ยท YoY N/A vs +2.3%
Momentum & Technical Winner IART
1Y -1.4% vs +18.8% ยท 52W Pos 2% vs 39%
Options & Structure Winner IART
UNCLASSIFIED (N/A IV) vs BREAKDOWN (16th %ile IV)
THOR US Equity
THOR
Institutional Equity
$24.63
-1.7% 1D
Market Cap N/A
1M Return -3.92%
1Y Return -1.43%
Forward P/E N/M
Unified AI Score
44.5 / 100 HOLD
Tech 27.0 Fund 50.0 Flow 50.0 Mom 60.0
IART NASDAQ
Integra LifeSciences Holdings
Surgical & Medical Instruments & Apparatus
$13.25
-2.21% 1D
Market Cap $1.1B
1M Return +7.51%
1Y Return +18.83%
Forward P/E 5.6x
Unified AI Score
45.5 / 100 HOLD
Tech 43.0 Fund 53.0 Flow 68.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: THOR -1.43% IART +18.83% Spread: +23.67 pp (THOR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
THOR TTM Op. Margin: N/A IART TTM Op. Margin: 9.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on THOR vs IART. Trailing 12-month operating profitability (THOR N/A vs IART 9.9%) and valuation multiples (THOR N/M vs IART 5.6x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: THOR (1) vs IART (9)
Institutional Metric THOR IART Criterion Row Winner
Market Capitalization Scale N/A $1.1B Larger Scale IART
Trailing P/E Ratio Valuation N/M 79.7x Lower Multiple IART
Forward P/E Ratio Valuation N/M 5.6x Lower Multiple IART
Revenue Growth (YoY) Growth N/A +2.3% Higher Growth IART
Operating Margin (TTM) Profitability N/A 9.9% Higher Margin IART
Net Profit Margin Profitability N/A 0.8% Higher Margin IART
Return on Equity (ROE) Capital Efficiency N/A 1.2% Higher ROE IART
52-Week Range Position Momentum 2% ($25โ€“$29) 39% ($9โ€“$20) Stronger Trend IART
Beta / 30D Volatility Risk Regime 0.46ฮฒ ยท 17% Vol 1.54ฮฒ ยท 60% Vol Lower Realized Risk THOR
Unified Institutional Score Composite Signal 44.5 / 100 (HOLD) 45.5 / 100 (HOLD) Higher Composite IART

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full THOR vs IART Buy Guide
THOR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live THOR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IART BREAKDOWN
103d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 16th %ile
IV Regime Compressed (<25th %ile)
Live IART Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither THOR nor IART registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.